Luise Pohnert
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Luise Pohnert has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Ettner-Sitter
Institute for Molecular and Cellular Anatomy University of Regensburg Regensburg Germany uni-regensburg.de
1 shared publication - Benedikt J. Wagner
Department of Surgery University Hospital Regensburg Regensburg Germany uniklinikum-regensburg.de
1 shared publication Christian Gröger
Department of Radiotherapy University Hospital Regensburg Regensburg Germany uniklinikum-regensburg.de
1 shared publicationChristina Hackl
Department of Surgery University Hospital Regensburg Regensburg Germany uniklinikum-regensburg.de
1 shared publication- Dharini Srinivasan
Ulm University Hospital 1 Institute of Molecular Oncology and Stem Cell Biology Ulm, Germany
1 shared publication - Dieter Fuchs
FUJIFILM VisualSonics Inc. Amsterdam the Netherlands visualsonics.com
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Biomedical Imaging
- Vol. 2026 (1)
High‐Resolution Imaging via UHF‐US–Based 3D Reconstruction in a 3D In Vivo Tumor Model
The chorioallantoic membrane (CAM) model resembles a preclinical in vivo platform for the engraftment of different tumors and is especially well‐suited for the development and evaluation of novel cancer therapies. Due to the CAM′s extensive vascular network, it can sustain engrafted human tumor tissue, which can be used for therapy testing and analysis throughout the experimental process. Although numerous studies have demonstrated successful tumor engraftment and vascular integration into the CAM′s blood vessel network, the accurate and sequential measurement of tumor volume remains a significant challenge. Current imaging modalities, such as positron emission tomography/computed tomography, magnetic resonance imaging or three‐dimensional (3D) digital microscopy are limited by cost, complexity, and potential harm due to injected agents or radiation. This study introduces an innovative imaging approach by utilizing ultrahigh frequency (UHF) ultrasound combined with 3D ultrasound reconstruction of pancreatic ductal adenocarcinoma (PDAC) on the CAM. By utilizing ultrasound frequencies of up to 71 MHz, two‐dimensional (2D) imaging of PDAC tumors was transformed into comprehensive 3D reconstructions. This innovative approach provides a more detailed tissue resolution and enables noninvasive, longitudinal volumetric monitoring of tumor growth in vivo, and in principle provides a platform for future studies assessing angiogenesis and therapy response. In this study the accuracy of 3D UHF ultrasound was tested by comparing it with established imaging techniques such as 3D digital microscopy. In summary, the 3D ultrasound reconstruction resembles a more versatile noninvasive alternative for in vivo tumor volume measurement. This advanced imaging approach adds a valuable methodology for the investigation of tumor biology in the CAM model by providing noninvasive volumetric and morphological characterization of engrafted tumor tissue, thereby linking preclinical research and clinical applications.
- 1 January 2026
- Published by Wiley in International Journal of Biomedical Imaging
- Vol. 2026 (1)
Open AccessHigh‐Resolution Imaging via UHF‐US–Based 3D Reconstruction in a 3D In Vivo Tumor Model
The chorioallantoic membrane (CAM) model resembles a preclinical in vivo platform for the engraftment of different tumors and is especially well‐suited for the development and evaluation of novel cancer therapies. Due to the CAM′s extensive vascular network, it can sustain engrafted human tumor tissue, which can be used for therapy testing and analysis throughout the experimental process. Although numerous studies have demonstrated successful tumor engraftment and vascular integration into the CAM′s blood vessel network, the accurate and sequential measurement of tumor volume remains a significant challenge. Current imaging modalities, such as positron emission tomography/computed tomography, magnetic resonance imaging or three‐dimensional (3D) digital microscopy are limited by cost, complexity, and potential harm due to injected agents or radiation. This study introduces an innovative imaging approach by utilizing ultrahigh frequency (UHF) ultrasound combined with 3D ultrasound reconstruction of pancreatic ductal adenocarcinoma (PDAC) on the CAM. By utilizing ultrasound frequencies of up to 71 MHz, two‐dimensional (2D) imaging of PDAC tumors was transformed into comprehensive 3D reconstructions. This innovative approach provides a more detailed tissue resolution and enables noninvasive, longitudinal volumetric monitoring of tumor growth in vivo, and in principle provides a platform for future studies assessing angiogenesis and therapy response. In this study the accuracy of 3D UHF ultrasound was tested by comparing it with established imaging techniques such as 3D digital microscopy. In summary, the 3D ultrasound reconstruction resembles a more versatile noninvasive alternative for in vivo tumor volume measurement. This advanced imaging approach adds a valuable methodology for the investigation of tumor biology in the CAM model by providing noninvasive volumetric and morphological characterization of engrafted tumor tissue, thereby linking preclinical research and clinical applications.